Free Access
Reprod. Nutr. Dev.
Volume 45, Number 2, March-April 2005
Page(s) 185 - 192
References of Reprod. Nutr. Dev. 45 185-192
  1. Soroko S, Holbrook TL, Edelstein S, Barrett-Connor E. Lifetime milk consumption and bone mineral density in older women. Am J Public Health 1994, 84: 1319-1322 [PubMed].
  2. Chen YT, Mattison DR, Feigenbaum L, Fukui H, Schulman JD. Reduction in oocyte number following prenatal exposure to a diet high in galactose. Science 1981, 214: 1145-1147.
  3. Swartz WJ, Mattison DR. Galactose inhibition of ovulation in mice. Fertil Steril 1988, 49: 522-526 [PubMed].
  4. Meyer WR, Doyle MB, Grifo JA, Lipetz KJ, Oates PJ, DeCherney AH, Diamond MP. Aldose reductase inhibition prevents galactose-induced ovarian dysfunction in the Sprague-Dawley rat. Am J Obstet Gynecol 1992, 167: 1837-1843 [PubMed].
  5. Xu YK, Ng WG, Kaufman FR, Lobo RA, Donnell GN. Galactose metabolism in human ovarian tissue. Pediatr Res 1989, 25: 151-155 [PubMed].
  6. Cramer DW, Harlow BL, Willett WC, Welch WR, Bell DA, Scully RE, Ng WG, Knapp RC. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989, 2: 66-71 [PubMed].
  7. Cooper GS, Hulka BS, Baird DD, Savitz DA, Hughes CL Jr, Weinberg CR, Coleman RA, Shields JM. Galactose consumption, metabolism, and follicle-stimulating hormone concentrations in women of late reproductive age. Fertil Steril 1994, 62: 1168-1175 [PubMed].
  8. Robb-Nicholson C. I read recently that there may be a connection between ovarian cancer and the consumption of dairy products, particularly cottage cheese and yogurt. Has this connection been proven? Harv Womens Health Watch 1998, 6: 8.
  9. Engle A, Muscat JE, Harris RE. Nutritional risk factors and ovarian cancer. Nutr Cancer 1991, 15: 239-247 [PubMed].
  10. Mettlin CJ. Invited commentary: progress in the nutritional epidemiology of ovary cancer. Am J Epidemiol 1991, 134: 457-459 [PubMed]; discussion 460-451.
  11. Webb PM, Bain CJ, Purdie DM, Harvey PW, Green A. Milk consumption, galactose metabolism and ovarian cancer (Australia). Cancer Causes Control 1998, 9: 637-644 [CrossRef] [PubMed].
  12. Risch HA, Jain M, Marrett LD, Howe GR. Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada). Cancer Causes Control 1994, 5: 540-548 [PubMed].
  13. Goodman MT, Wu AH, Tung KH, McDuffie K, Cramer DW, Wilkens LR, Terada K, Reichardt JK, Ng WG. Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancer. Am J Epidemiol 2002, 156: 693-701 [CrossRef] [PubMed].
  14. Fung WL, Risch H, McLaughlin J, Rosen B, Cole D, Vesprini D, Narod SA. The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2003, 12: 678-680 [PubMed].
  15. Cozen W, Peters R, Reichardt JK, Ng W, Felix JC, Wan P, Pike MC. Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control 2002, 13: 113-120 [CrossRef] [PubMed].
  16. Cooper RL, Goldman JM, Vandenbergh JG. Monitoring of the estrous cycle in the laboratory rodent by vaginal lavage. In: Heindel JJ, Chapin RE (Eds), Female Reproductive toxicity, Academic Press, Inc, New York, 1993, p 45-56.
  17. Plowchalk DR, Smith B, Mattiso DR. Assessment of toxicity to the ovary using follicle quantitation and morphometrics. In: Heindel JJ, Chapin RE (Eds), Methods in Toxicology-Female Reproductive Toxicology, Academic Press, Inc, 1993, p 57-68.
  18. Liu G, Hughes CL, Mathur R, Foster WG, Davis VL, Magoffin DA. Metabolic effects of dietary lactose in adult female rats. Reprod Nutr Dev 2003, 43: 567-576 [EDP Sciences] [CrossRef] [PubMed].
  19. Lu JK, LaPolt PS, Nass TE, Matt DW, Judd HL. Relation of circulating estradiol and progesterone to gonadotropin secretion and estrous cyclicity in aging female rats. Endocrinology 1985, 116: 1953-1959 [PubMed].
  20. Anzalone CR, Lu JK, LaPolt PS. Influences of age and reproductive status on ovarian ovulatory responsiveness to gonadotropin stimulation. Proc Soc Exp Biol Med 1998, 217: 455-460 [PubMed].
  21. LaPolt PS, Matt DW, Lu JK. Progesterone implants delay age-related declines in regular estrous cyclicity and the ovarian follicular reserve in Long-Evans rats. Biol Reprod 1998, 59: 197-201 [PubMed].
  22. Matt DW, Server PL, Lu JK. Relation of parity and estrous cyclicity to the biology of pregnancy in aging female rats. Biol Reprod 1987, 37: 421-430 [PubMed].
  23. Liu GG, Huang H, Wang RL, Hughes CL. Taurine prevents ovarian toxicity of galactose in Japanese Quail. Jiangsu J Agric Sci 2001, 17: 44-48.
  24. Williams CA, Phillips T, Macdonald I. The influence of glucose on serum galactose levels in man. Metabolism 1983, 32: 250-256 [CrossRef] [PubMed].
  25. Rogers S, Segal S. Changing activities of galactose metabolizing enzymes during perfusing of suckling rat liver. Am J. Physiol 1981, 240: 333-339.
  26. Crane RK. Digestion and absorption: water soluble organics. International Review of Physiology, 12th ed, Crane RK (Ed), University Park Press, 1977.
  27. Holdsworth CD, Dawson AM. The absorption of monosaccharides in man. Clin Sci 1964, 27: 371-379 [PubMed].